Portfolio
Labyrinth Biotech Inc
Microfluidic technology for the isolation and capture of circulating tumor cells for research purposes and clinical diagnosis(2020)
LynxDX, Inc
Biotechnology startup using prostate cancer diagnostic assay to measure levels of cancer specific genes in the urine. Additionally focused on scaling COVID-19 testing(2020)
MONSTR Sense Technologies
Ultrafast and coherent spectroscopy microscopes for semiconductor defect inspection and advanced research(2020)
Novlead Biotech
Medical devices that release nitric oxide to treat persistent pulmonary hypertension of the newborn(2020)
NuBundle, Inc.
Suite of software and services for patients undergoing assisted reproduction treatment(2020)
OntMed
Medical ontology and classification system used to improve search, interogation and analysis of a variety of medical data(2020)
Photon Semantics
Computer vision neural network enabling material sensing within optical sensors including LIDAR and cameras(2020)
PTM Therapeutics
Antibody therapeutic for the treatment of inflammatory bowel disease(2020)
Refraction AI, Inc
Robotic platform for providing safe and scalable goods delivery in urban areas(2020)
S3D Precision Dispensing, Inc
Enabling digital manufacturing; dispensing lubricants, OLED materials and bio-fluids with micron-scale features onto existing surfaces(2020)
Smart Production Systems
Automating managerial decision-making on the factory floor(2020)
Zakuro
Safer solid-state batteries with double the energy density of Li-ion batteries(2020)
Angio Insight
Automated analysis of angiograms to augment clinical decisions in managing coronary artery disease(2019)
Applied Morphomics Inc
Applied Morphomics, Inc. is a biomarker technology and development company targeting assessment of body factors essential for delivering precision medicine.(2019)
Arcascope
Apps developed using mathematical modeling to predict circadian rhythms to improve performance and wellness.(2019)
Cellf BIO LLC
Cellf BIO manufactures bioengineered sphincters using autologous progenitor cells that replace the dysfunctional internal anal sphincter, the root cause of FI. This new product, called a BioSphincterTM, allows the patient to regain full control of bowel movements and rejuvenate their quality of life.(2019)